Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1899247

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1899247

Vascular Patches Market Size, Share, and Growth Analysis, By Material (Biologic Vascular Patches, and Synthetic Vascular Patches), By Application (Carotid Endarterectomy, Aortic Aneurysms), By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Vascular Patches Market size was valued at USD 452.58 Million in 2024 and is poised to grow from USD 489.24 Million in 2025 to USD 912.28 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The prevalence of chronic kidney disease (CKD) significantly impacts the healthcare landscape, underpinning risks for various conditions such as diabetes, hypertension, and cardiovascular diseases. CKD is characterized by a gradual decline in kidney function, impairing the body's capability to regulate fluids, electrolytes, and waste, which can create serious health complications. With over 37 million adults in the United States diagnosed with this condition, the demand for effective treatments and interventions is crucial. This rising patient population highlights the increasing need for innovative solutions, such as vascular patches, that can address complications associated with CKD and improve patient outcomes. The market for vascular patches is poised for growth as healthcare providers seek advanced treatment options for managing CKD's ramifications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vascular Patches market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vascular Patches Market Segments Analysis

The global Vascular Patches Market is segmented into three segments i.e. by Material, Application and Region. Based on material, the market is segmented into Biologic Vascular Patches, Synthetic Vascular Patches. Based on Application, the market is segmented into Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, Other Applications. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver of the Vascular Patches Market

The increasing global aging population serves as a crucial driver for the growth of the vascular patches market. As individuals age, they are more susceptible to a variety of health issues, including cardiovascular diseases, high cholesterol, hypertension, strokes, cancer, and aneurysms. This demographic shift leads to a greater demand for medical interventions, particularly in cardiac health. The correlation between advancing age and the decline in cardiovascular wellness underscores the importance of this trend, highlighting the need for innovative solutions like vascular patches to address the escalating health challenges associated with an older population, thereby fostering market development.

Restraints in the Vascular Patches Market

One significant factor that may hinder growth in the vascular patches market is the increasing frequency of product recalls, which raises concerns about quality and safety. For example, notable healthcare companies have faced instances where vascular patches were recalled due to issues that could jeopardize patient safety. These events create apprehensions among healthcare providers and patients alike, potentially leading to decreased trust in these products. Consequently, such challenges can adversely affect market dynamics, influencing consumer confidence and the overall performance of the industry, ultimately restraining the anticipated growth of the vascular patches market.

Market Trends of the Vascular Patches Market

The Vascular Patches market is experiencing a notable upward trend driven by the rising adoption of minimally invasive surgical techniques, particularly in cardiac procedures such as MIDCAB. This shift is motivated by the enhanced safety and improved patient outcomes associated with these methods, leading to lower mortality rates. The compatibility of innovative surgical techniques, including coronary artery stent grafts, with existing cardiopulmonary bypass systems further propels demand for vascular grafts. As healthcare providers increasingly prioritize patient-centered approaches and economical solutions, the market for vascular patches is poised for robust growth, reflecting a broader movement toward advanced surgical interventions and improved patient care.

Product Code: SQMIG35A2805

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Vascular Patches Market Size by Material & CAGR (2026-2033)

  • Market Overview
  • Biologic Vascular Patches
  • Synthetic Vascular Patches

Global Vascular Patches Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Carotid Endarterectomy
  • Open Repair of Abdominal Aortic Aneurysm
  • Vascular Bypass Surgery
  • Congenital Heart Disease
  • Other Applications

Global Vascular Patches Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers

Global Vascular Patches Market Size & CAGR (2026-2033)

  • North America (Material, Application, End User)
    • US
    • Canada
  • Europe (Material, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Material, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Material, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Material, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LeMaitre Vascular, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artivion, Inc. (formerly CryoLife, Inc.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aziyo Biologics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vascudyne, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Collagen Solutions Plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FOC Medical S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Obex Medical Ltd. (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vascumed (Pty) Ltd. (South Africa)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celox Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biom'up (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hemovent GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kuros Biosciences AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!